Ketoprofen Lysine Salt vs. Ketoprofen Acid: Assessing the Evidence for Enhanced Safety and Efficacy
Life · 16.04.2025 · 15 (4) · 659
DOI: 10.3390/life15040659 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Life, online erschienen am 16.04.2025. Verfasst von Agnese Graziosi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Endoscopic investigations reveal that a significant majority of individuals taking NSAIDs exhibit acute hemorrhages and mucosal erosions within the gastroduodenal lining. Ketoprofen acid (KA) is a potent NSAID with established efficacy and cardiovascular tolerability, but its gastric tolerability is a recognized limitation. To mitigate this, ketoprofen lysine salt (KLS) was developed. This review evaluates the pharmacological advantages of KLS over KA. While both KA and KLS maintain similar potency, KLS offers distinct advantages. Firstly, KLS demonstrates superior gastrointestinal protection through enhanced antioxidant properties and upregulation of mucosal defenses, as evidenced by both in vitro and in vivo studies. Secondly, KLS exhibits significantly faster absorption, leading to a more rapid onset of analgesic effects; this is attributed to its increased solubility and faster achievement of therapeutic concentrations. In essence, KLS addresses the gastric tolerability issues of KA while providing a quicker onset of action, making it a valuable alternative for patients requiring NSAID therapy, particularly those with gastric sensitivities or in need of rapid pain relief.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.
- Chemical-Clinical Analysis Unit, ASST Grande Ospedale Metropolitano Niguarda, 20162 Milan, Italy.
- Department of General Surgery and Surgical Specialty Paride Stefanini, Sapienza University of Rome, 00185 Rome, Italy.
- Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, 20162 Milan, Italy.
ORCID-Profile: Gianluca Gazzaniga, Stefano Agliardi, Arianna Pani, Francesco Scaglione
Zitieren
APA
Graziosi, A., Senatore, M., Gazzaniga, G., Agliardi, S., Pani, A., & Scaglione, F. (2025). Ketoprofen Lysine Salt vs. Ketoprofen Acid: Assessing the Evidence for Enhanced Safety and Efficacy. Life, 15(4), 659. https://doi.org/10.3390/life15040659
Vancouver
Graziosi A, Senatore M, Gazzaniga G, Agliardi S, Pani A, Scaglione F. Ketoprofen Lysine Salt vs. Ketoprofen Acid: Assessing the Evidence for Enhanced Safety and Efficacy. Life. 2025;15(4):659. doi:10.3390/life15040659
BibTeX
@article{Graziosi2025,
author = {Graziosi, Agnese and Senatore, Michele and Gazzaniga, Gianluca and Agliardi, Stefano and Pani, Arianna and Scaglione, Francesco},
title = {Ketoprofen Lysine Salt vs. Ketoprofen Acid: Assessing the Evidence for Enhanced Safety and Efficacy},
journal = {Life},
year = {2025},
volume = {15},
number = {4},
pages = {659},
doi = {10.3390/life15040659}
}
EUVIMED